NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

You are wrong in my opinion. Investor relations is being involved with investors to attract, keep , mollify and encourage them. After all, they are part owners of the company. As such, DI is also an advocate for shareholders and before joining NWBO he was also dissatisfied with the company's strategy of silence and lack of transparency. He wanted to fix that and presumably that was one of the reasons he joined NWBO. Shareholders are interested in preservation of value, where a company can take steps to do so. While I did not expect top line, I did expect a better presentation which could have served to mitigate a downdraft in price. I have made suggestions on how this could have been done in other posts. It is not rocket science.

As I have said, as far as I can see, DI is a musical chairs replacement for LG who thus far, IMHO, has effected no noticeable change in the company's investor relation activities such as they are. ASCO would have been a great opportunity for him to have made some impact, but there was none, either because he believes this was the best way to go, he disagreed but had no influence or he was not consulted beforehand. As you say.....different strokes for different folks.